ARCHIVES

NIH, FDA to tighten, review consulting rules as Congressional inquiry continues.

This article is from The Cancer Letter archive.

Vol. 30 No. 21 | May 21, 2004

Download PDF Visit The Full Archive

Related Articles

Turmoil in Texas: AVEO, DePinho Joined at the Hip (Pocket)

May 8, 2013

Duke Halts Third Trial; Coauthor Disputes Claim That Data Validation Was Blinded

October 23, 2009

FDA Oncology Unit Fastest in Approvals Despite Having Highest Workload

May 9, 2014

Some NCI Advisors Tell GAO Congress “Jumped The Gun” In Creating Cancer Control Program

October 26, 1979

Phase III Vaccine Trial Fails To Improve Overall Survival

October 25, 2013

Phase III Cyramza Trial Meets OS Primary Endpoint

September 26, 2014